C4 Therapeutics
CCCC
CCCC
113 hedge funds and large institutions have $232M invested in C4 Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
25
Increased
38
Reduced
33
Closed
29
Calls
$2.35M
Puts
$425K
Net Calls
+$1.92M
Net Calls Change
-$2.03M
Top Buyers
| 1 |
SC
Samlyn Capital
New York
|
$10.9M |
| 2 |
Morgan Stanley
New York
|
$13.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$5.58M |
| 4 |
BlackRock
New York
|
$20M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$2.73M |
